Skip to main content
. 2022 Jun 22;45(4):779–784. doi: 10.1016/j.rbmo.2022.06.015

Table 2.

Indications for treatment

Indication
Male factor 9 (29.0)
Unexplained 5 (16.1)
Low ovarian reserve 3 (9.7)
Tubal factor 1 (3.2)
Social fertility preservation 4 (12.9)
Anovulation 1 (3.2)
PGT-M 3 (9.7)
Repeated miscarriage 1 (3.2)
Advanced maternal age 3 (9.7)
Female partner 1 (3.2)

Data are presented as n (%).

PGT-M, preimplantation genetic testing for monogenic/single gene defects.